Results 171 to 180 of about 82,603 (308)

Antithrombin: Deficiency, Diversity, and the Future of Diagnostics

open access: yesMass Spectrometry Reviews, EarlyView.
ABSTRACT Our healthcare system provides reactive sick‐care, treating patients after symptoms have appeared by prescription of generic and often suboptimal therapy. This strategy brings along high costs and high pressure which is not sustainable.
Mirjam Kruijt   +2 more
wiley   +1 more source

Outcomes and Risk Factors in Oncologic Temporal Bone Surgery: A Head and Neck‐Specific NSQIP Analysis

open access: yesOtolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective Advanced temporal bone and parotid gland malignancies are rare and difficult to manage. However, complications of oncologic temporal bone surgery have not been systematically categorized. We aim to detail the postoperative outcomes of lateral temporal bone resection (LTBR) and mastoidectomy for otologic oncology patients, and ...
Bailey H. Duhon   +5 more
wiley   +1 more source

Screening and Functional Analysis of tsRNAs Associated with Diabetic Foot Ulcer Tissues. [PDF]

open access: yesBiomedicines
He X   +8 more
europepmc   +1 more source

Persistent Facial Nodules in an Elderly Patient

open access: yes
JEADV Clinical Practice, EarlyView.
Qian Ding   +2 more
wiley   +1 more source

Characteristics, properties and limitations of per‐ or polyfluoroalkyl substances (PFASs) and fluoropolymers

open access: yesPolymer International, EarlyView.
An overview and categorization of man‐made per‐ or polyfluoroalkyl substances (PFASs) including low‐molar‐mass and high‐molar‐mass fluorochemicals, and their international regulations is presented. Though certain PFASs are toxic, bioaccumulative and cross the human cellular membranes, others, such as fluoropolymers, are safe, reliable and involved in ...
Bruno Améduri
wiley   +1 more source

Hyperpigmented Plantar Rash in a Confused Patient With New HIV Diagnosis: Syphilis or Kaposi Sarcoma?

open access: yes
JEADV Clinical Practice, EarlyView.
Claudine Howard‐James   +3 more
wiley   +1 more source

Corticosteroid Use and Risk of Adverse Events in Metastatic Hormone‐Sensitive Prostate Cancer

open access: yesThe Prostate, EarlyView.
ABSTRACT Background Among the approved therapies for metastatic hormone‐sensitive prostate cancer (mHSPC), abiraterone and docetaxel are administered concomitantly with corticosteroids. This study evaluated the association between corticosteroid use and risk of adverse events among patients with mHSPC. Methods We conducted an observational cohort study
Umang Swami   +8 more
wiley   +1 more source

Osteomyelitis and Its Main Determinants in Patients With Diabetic Foot Ulcer: A Cross-Sectional Study. [PDF]

open access: yesHealth Sci Rep
Bolandi S   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy